Biotech BioLineRx to Participate in the 12th Annual LifeSci Partners Corporate Access Event November 28, 2022
Biotech SHAREHOLDER ALERT: Pomerantz Law Firm Reminds Shareholders with Losses on their Investment in Eiger BioPharmaceuticals, Inc., of Class Action Lawsuit and Upcoming Deadline – EIGR November 28, 2022
Biotech *FINAL REMINDER* AGTC Urges Shareholders to Tender Their Shares by November 28, 2022 *FINAL REMINDER* November 28, 2022
Biotech ContraFect Announces ANSM Approval of Clinical Trial Application for Exebacase in Prosthetic Joint Infections November 28, 2022
Biotech Galectin Therapeutics to Present at 6th Obesity & NASH Drug Development Summit November 28, 2022
Biotech Cidara Therapeutics and Melinta Therapeutics Announce Publication of Data from the Global Phase 3 Pivotal ReSTORE Trial of Rezafungin for the Treatment of Candidemia and Invasive Candidiasis in The Lancet November 28, 2022
Biotech Nabriva Therapeutics Announces Positive Topline Results from Phase 1 Trial of XENLETA® (lefamulin) in Adult Patients with Cystic Fibrosis November 28, 2022
Biotech Anavex Life Sciences Reports Fiscal 2022 Year End Financial Results and Provides Business Update November 28, 2022
Biotech Securities Litigation Partner James (Josh) Wilson Encourages Investors Who Suffered Losses Exceeding $50,000 In Eyepoint To Contact Him Directly To Discuss Their Options November 27, 2022
Search
xbi stock
November 28, 2022
November 28, 2022
November 28, 2022
November 28, 2022
November 28, 2022
November 28, 2022
November 28, 2022
November 28, 2022
November 28, 2022
November 27, 2022
